of PKC isozymes to different subcellular locations is believed to be at least partly responsible for controlling the substrate selectivity of PKC by localizing the enzyme near its substrates but away from other proteins [11] .
of experiments was performed at 37ЊC to determine the extent to which temperature influenced the relative cence intensity measured at the plasma membrane to that at the nuclear membrane once translocation was rates. The results at 37ЊC were indistinguishable from those at room temperature (data not shown). Figure 4 complete was approximately 1:1. All three ratios were identical within error.
shows the decrease in cytosolic fluorescence after the addition of bryostatin 1, analog 1, or analog 2 (200 nM).
In order to ensure that the observed nuclear membrane localization was not a result of translocation of
The data was measured as the decrease in cytosolic fluorescence to avoid artifacts and difficulties related the kinase domain-GFP fragment after proteolysis, RBL cells were transfected with PKC␦-GFP and exposed to to ruffling and movement of the membrane, which was observed in several of the experiments. bryostatin 1 (200 nM) or analog 2 (200 nM) for 30 min.
The lysates of these cells were examined by Western
For all three compounds, both the rate of translocation and the overall degree of translocation was dose de-blot with both a monoclonal anti-GFP antibody and a polyclonal antibody to PKC␦. There was no increase pendent, with lower doses resulting in slower and less complete translocation ( Figures 5 and 6 ). At a given in the amount of cleavage product in either the cells exposed to bryostatin 1 or analog 2 when compared to concentration, analog 1 and 2 induced much faster translocation than bryostatin 1. Shown in Figure 6 are cells that had not been exposed to any agent (data not shown). This result is consistent with that obtained by plots of the measured half-lives for the translocation of PKC␦-GFP in response to the analogs and bryostatin 1 Blumberg and coworkers in PKC␦-GFP-overexpressing CHO cells and indicates that the observed localization as well as the degree of translocation in response to each agent. The measured half-life was calculated as to the nuclear membrane is induced by the test molecules [18, 19] While binding affinities to PKC can serve cation induced by analog 1 and analog 2 remained similar, but was significantly greater than that induced by as indicators of potential interactions in biological systems, they often do not correlate with specific biological bryostatin 1. When dosed at 1 nM, the response of PKC␦-GFP to analog 1 and analog 2 differed, with analog function. This is not surprising, as binding, a thermodynamic parameter, is not always connected to function, 2 resulting in greater translocation than analog 1 or bryostatin 1. a kinetic parameter. For example, bryostatin and analog 1 have comparable binding affinities to PKC, whereas In addition to the observed differences in kinetics, the analogs also retained the ability to induce translocation both analogs 1 and 2 are orders of magnitude more potent at inhibiting the growth of many human cancer of PKC␦-GFP at lower doses than bryostatin 1. Figure  7 shows images of the cells after exposure to the agents. cell lines [15] . In order to elucidate the cascade of events that culminate in a cellular response to the phorbol es-Bryostatin 1 induced very little translocation at 5 nM, while both analogs 1 and 2 were still effective at inducing ters, bryostatin, and analogs of bryostatin, a more comprehensive understanding of the response of PKC and translocation of PKC to the plasma membrane. While treatment with analog 1 resulted in marginal transloca-other proteins that contain C1 binding domains is re- proteins were chosen for characterizing the relative the same for analog 1 and 2, but that these analogs are both faster than bryostatin 1. However, between the function of bryostatin and its analogs.
. Current understanding of PKC activity PKC␦ is implicated as an important isozyme of PKC for determining the response of living systems to tumor-attributes the substrate specificity of PKC at least in part to its subcellular localization upon activation [22]. ogenesis induced by the phorbol esters [20]. PKC␦ is integral to certain apoptosis pathways and might also Therefore, different patterns of localization of PKC isozymes might account for the differing cellular responses play a role in the metastatic potential of cancer cells [21]. Blumberg and coworkers have also shown that the to PKC activation. For these reasons, PKC␦-GFP fusion
The results of these experiments show that analogs ranges of 5 nM and 1 nM, the rate at which analogs 1 and 2 induce translocation PKC␦-GFP becomes different.
and 2 are significantly more potent than bryostatin at inducing translocation of PKC␦-GFP but induce a similar A possible explanation for the difference in translocation potency between bryostatin and the analogs is pattern of translocation. At concentrations of 200 and 50 nM, bryostatin induces an initial translocation of that the lipophilicity of these molecules might play a role in determining the potency and rate of the cellular PKC␦-GFP to the plasma membrane. Translocation of PKC␦-GFP to the nuclear membrane in response to bry-response. The modified spacer domains present in both
1 and 2 might alter their lipophilicity, which in turn could ostatin 1 is slower and is not observed until approximately 5-10 min after administration (Figure 2) . In re-affect their diffusion through cells and partitioning among various cellular compartments. As the binding event with sponse to 200 or 50 nM concentrations of analogs 1 and 2, however, there is a rapid localization of PKC␦-PKC and bryostatin 1 or the analogs involves a tertiary complex of membrane, ligand, and protein, changing GFP to the plasma and nuclear membranes simultaneously.
the interaction of the ligand with the membrane could significantly alter the kinetics and thermodynamics of Another interesting result is that the rate of PKC␦-GFP translocation at higher concentrations (Ն5 nM) is the interaction. We have shown that, in contrast to their binding affinities, synthetic analogs of bryostatin are more potent at
